Modulation of Cellular Immune Function by Cyclophosphamide in Children with Minimal-Change Nephropathy
- 16 February 1984
- journal article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 310 (7), 415-420
- https://doi.org/10.1056/nejm198402163100702
Abstract
Cyclophosphamide is widely used to induce a remission of minimal-change nephropathy, but concerns have been raised about whether its effects on cellular immunity persist after treatment is discontinued.Keywords
This publication has 22 references indexed in Scilit:
- FATAL HAEMORRHAGIC CHICKENPOX IN A CHILD ON LONG-TERM STEROIDSThe Lancet, 1981
- GONADAL FUNCTION IN BOYS WITH STEROID-RESPONSIVE NEPHROTIC SYNDROME TREATED WITH CYCLOPHOSPHAMIDE FOR SHORT PERIODSThe Lancet, 1981
- The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone: A report of the international study of kidney disease in childrenThe Journal of Pediatrics, 1981
- LONG-TERM IMPAIRMENT OF SUPPRESSOR-CELL FUNCTION BY CYCLOPHOSPHAMIDE IN MINIMAL-CHANGE NEPHROPATHY AND ITS ASSOCIATION WITH THERAPEUTIC RESPONSEThe Lancet, 1981
- Lymphocyte Subpopulations in Minimal-Change NephropathyNephron, 1980
- A serum inhibitor of blastogenesis in idiopathic nephrotic syndrome transferred by lymphocytesClinical Immunology and Immunopathology, 1979
- VASCULAR PERMEABILITY FACTOR AND NEPHROTIC SYNDROMEThe Lancet, 1978
- Dissociation of lymphokine production and blastogenesis in children with measles infectionsClinical Immunology and Immunopathology, 1978
- Postpubertal evaluation of gonadal function following cyclophosphamide therapy before and during pubertyThe Journal of Pediatrics, 1977
- HODGKIN'S DISEASE AND LIPOID NEPHROSISThe Lancet, 1977